L3VLUP
ProSign in

CRSP · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CRSPARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CRSP
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterCRSPARGX
Q3 20204 holders, $763m8 holders, $3.6bn
Q4 20209 holders, $2.0bn7 holders, $4.1bn
Q1 20214 holders, $1.3bn8 holders, $4.1bn
Q2 20214 holders, $1.5bn9 holders, $4.6bn
Q3 20214 holders, $903m8 holders, $4.5bn
Q4 20214 holders, $781m9 holders, $5.3bn
Q1 20226 holders, $696m8 holders, $5.3bn
Q2 20226 holders, $799m13 holders, $6.5bn
Q3 20225 holders, $603m14 holders, $5.3bn
Q4 20226 holders, $369m13 holders, $5.5bn
Q1 20234 holders, $380m13 holders, $5.9bn
Q2 20236 holders, $483m18 holders, $6.6bn
Q3 20234 holders, $354m21 holders, $8.7bn
Q4 20234 holders, $609m17 holders, $6.3bn
Q1 20244 holders, $595m13 holders, $6.8bn
Q2 20245 holders, $480m14 holders, $7.9bn
Q3 20244 holders, $403m13 holders, $10.7bn
Q4 20242 holders, $388m14 holders, $12.3bn
Q1 20253 holders, $414m17 holders, $11.8bn
Q2 20254 holders, $643m18 holders, $10.8bn
Q3 20254 holders, $748m16 holders, $13.8bn
Q4 20251 holders, $552m16 holders, $14.8bn
Q1 20264 holders, $840m11 holders, $12.3bn
Q2 20263 holders, $883m14 holders, $15.0bn
CRSP

Crispr Therapeutics AG

Holders
4
Reported value
$748m
Buyers
0
Sellers
4

Breadth -4 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
16
Reported value
$13.8bn
Buyers
10
Sellers
7

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q3 2025

Among the 17 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only CRSP (1)

ARK Investment Management LLC

Only ARGX (13)

Acadian Asset Management LLC, Artisan Partners LP, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Fidelity (FMR LLC), Hudson Bay Capital Management LP, Janus Henderson Group Ltd, Millennium Management LLC, Moore Capital Management LP, T. Rowe Price Associates Inc, Voloridge Investment Management LLC, Wellington Management Group LLP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →